ES2070488T3 - Procedimiento para la deteccion de enfermedades malignas. - Google Patents

Procedimiento para la deteccion de enfermedades malignas.

Info

Publication number
ES2070488T3
ES2070488T3 ES91902191T ES91902191T ES2070488T3 ES 2070488 T3 ES2070488 T3 ES 2070488T3 ES 91902191 T ES91902191 T ES 91902191T ES 91902191 T ES91902191 T ES 91902191T ES 2070488 T3 ES2070488 T3 ES 2070488T3
Authority
ES
Spain
Prior art keywords
pct
receptors
detection
malignant diseases
date jul
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91902191T
Other languages
English (en)
Other versions
ES2070488T5 (es
Inventor
Heinz Bodenmuller
Andreas Dessauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6396458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2070488(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES2070488T3 publication Critical patent/ES2070488T3/es
Application granted granted Critical
Publication of ES2070488T5 publication Critical patent/ES2070488T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Abstract

PARA DETECTAR ENFERMEDADES MALIGNAS SE INCUBA UNA MUESTRA DE UN LIQUIDO DEL CUERPO CON DOS RECEPTORES, R SUB 1 Y R SUB 2, POR LO MENOS Y SE PRODUCE UNA VARIACION EN LA SEÑAL ENLAZANDO POR LO MENOS LOS RECEPTORES R SUB 1 Y R SUB 2 A UNA SUSTANCIA QUE VA A SER DETECTADA EN LA SOLUCION DE MUESTRA. UNO DE LOS DOS RECEPTORES CONTIENE UN ANTICUERPO MONOCLONAL QUE ENLAZA LA SECUENCIA AMINOACIDA (291 A 335) DE CITOCESATINA (19) Y EL OTRO RECEPTOR CONTIENE UN ANTICUERPO MONOCLONAL QUE ENLAZA LA SECUENCIA AMINOACIDA (346 A 367) DE CITOCERATINA (19) Y DETERMINA LA VARIACION DE LA SEÑAL DEBIDA AL ENLACE.
ES91902191T 1989-12-27 1990-12-27 Procedimiento para la diagnosis de enfermedades tumorales. Expired - Lifetime ES2070488T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3942999A DE3942999C2 (de) 1989-12-27 1989-12-27 Verfahren zum Nachweis von malignen Erkrankungen

Publications (2)

Publication Number Publication Date
ES2070488T3 true ES2070488T3 (es) 1995-06-01
ES2070488T5 ES2070488T5 (es) 2002-07-01

Family

ID=6396458

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91902191T Expired - Lifetime ES2070488T5 (es) 1989-12-27 1990-12-27 Procedimiento para la diagnosis de enfermedades tumorales.

Country Status (9)

Country Link
US (1) US5288614A (es)
EP (1) EP0460190B2 (es)
JP (1) JPH082919B2 (es)
AT (1) ATE120550T1 (es)
CA (1) CA2046888A1 (es)
DE (2) DE3942999C2 (es)
DK (1) DK0460190T3 (es)
ES (1) ES2070488T5 (es)
WO (1) WO1991010139A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4208422A1 (de) * 1992-03-16 1993-09-30 Boehringer Mannheim Gmbh Verfahren zum Nachweis von Mikrometastasen ekto- oder entodermaler Tumoren
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
WO1999014372A1 (en) * 1997-09-15 1999-03-25 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
DE19855819C2 (de) * 1998-12-03 2001-02-15 Roche Diagnostics Gmbh Stabilisierung von Cytokeratin enthaltenden Kalibratoren
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
JPWO2005043166A1 (ja) * 2003-10-30 2007-11-29 シスメックス株式会社 子宮腺癌の診断薬及び腺癌細胞の検出方法
WO2007076439A2 (en) * 2005-12-22 2007-07-05 Abbott Laboratories Methods and marker combinations for screening for predisposition to lung cancer
CN101583722A (zh) * 2006-07-14 2009-11-18 阿维瓦生物科学股份有限公司 从生物学样品检测稀有细胞的方法和组合物
ATE522813T1 (de) * 2006-09-07 2011-09-15 Universitaetsklinikum Hamburg Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen
CN103476428B (zh) 2010-09-09 2016-10-26 北京同为时代生物技术有限公司 用于诊断上皮源性癌症的血液标志物及其单克隆抗体
JP6352909B2 (ja) 2012-06-27 2018-07-04 バーグ エルエルシー 前立腺癌の診断および処置におけるマーカーの使用
KR102280473B1 (ko) * 2014-02-05 2021-07-22 후지레비오 디아그노스틱스 에이비 악성 신생물 질환의 검출을 위한 조성물 및 방법
CA2970143A1 (en) 2014-12-08 2016-06-16 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
JP6637290B2 (ja) * 2015-11-05 2020-01-29 武 永安 Ｃｋ１９に特異的なモノクローナル抗体およびこれを産生するハイブリドーマ、癌の検出キット、癌の検出方法および癌の転移の判定方法
US10301057B2 (en) 2016-07-11 2019-05-28 Calibre Closures Llc Dispensing container with internal squeeze limiting member
CN113061184B (zh) * 2021-04-25 2022-07-01 福州迈新生物技术开发有限公司 抗ck7蛋白单克隆抗体及其细胞株、制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003132A1 (en) * 1984-01-06 1985-07-18 The Regents Of The University Of California Cytokeratin tumor markers and assays for their detection
US4727021A (en) * 1984-06-01 1988-02-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cytokeratin
DE3815932A1 (de) * 1988-01-26 1989-08-03 Progen Biotechnik Gmbh Verfahren zur identifizierung des ursprungs einer zellgewebsprobe
DE3640412A1 (de) * 1986-11-26 1988-06-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz

Also Published As

Publication number Publication date
DE3942999C2 (de) 1997-12-18
EP0460190B2 (de) 2001-11-28
ES2070488T5 (es) 2002-07-01
EP0460190A1 (de) 1991-12-11
CA2046888A1 (en) 1991-06-28
JPH082919B2 (ja) 1996-01-17
US5288614A (en) 1994-02-22
EP0460190B1 (de) 1995-03-29
JPH04504063A (ja) 1992-07-23
DK0460190T3 (da) 1995-08-28
DE3942999A1 (de) 1991-07-04
WO1991010139A1 (de) 1991-07-11
ATE120550T1 (de) 1995-04-15
DE59008810D1 (de) 1995-05-04

Similar Documents

Publication Publication Date Title
ES2070488T3 (es) Procedimiento para la deteccion de enfermedades malignas.
KR870700637A (ko) 사이클로스포린에 대한 단일클론성 항체
Ehrlich et al. Cooperative immunoassays: ultrasensitive assays with mixed monoclonal antibodies
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
ES2089048T3 (es) Procedimiento para la deteccion de proteinas que contienen tirosina fosforilada.
ES2056154T3 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse especificamente.
DE69018968D1 (de) BLUTGERINNUNGSFAKTOR BETA XIIa MONOKLONALE ANTIKÖRPER UND IMMUNANALYSE.
DK0487718T3 (da) Nukleinsyreprober med negativt ladede haptener forbundet via hydrazinbindinger.
ATE188551T1 (de) Feststellung von antikörperproduktion
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
ES2026146T3 (es) Procedimiento para la preparacion de un medio de incubacion para ensayos inmunometricos en fase solida.
DK414386A (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
ES8705232A1 (es) Un metodo para preparar un anticuerpo monoclonal destinado autilizarse como auxiliar de diagnostico para detectar cancerde pulmon
ES2076221T3 (es) Derivados geminales de difenilo y su uso en inmunoensayos.
FI943921A (fi) Vapaan trypsinogeeni-2:n määritys
WO1990008956A1 (fr) Detection d'activateur de facteur tissulaire humain
ES8405155A1 (es) Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.
ES2178517B1 (es) Procedimiento para el estudio de la activacion funcional de leucocitos, plaquetas y otras celulas.
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 460190

Country of ref document: ES